Stent retriever having an expandable fragment guard

Information

  • Patent Grant
  • 11266435
  • Patent Number
    11,266,435
  • Date Filed
    Friday, December 20, 2019
    4 years ago
  • Date Issued
    Tuesday, March 8, 2022
    2 years ago
  • Inventors
  • Examiners
    • Miles; Wade
    Agents
    • Timothy E. Siegel Patent Law, PLLC
    • Siegel; Timothy E.
Abstract
A stent retriever assembly having a proximal end and a distal end and including a mesh tube having a distal and proximal end and being connected to a first wire. Also, a blood-porous fragment guard is at the distal end of the mesh tube and has a central hub and extending radially and proximally from the central hub. Further, a second wire is connected to the central hub, and when this second wire is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form.
Description
TECHNICAL FIELD

The invention is in the technical field of devices for treating blood vessel clots, and more particularly devices for removing clots that block a cerebral artery, which are equipped with a blood porous fragment guard that prevents fragments of material from lodging in the cerebral artery.


BACKGROUND

The medical arts have advanced rapidly in the area of stroke treatment. Until recently, only medicinal treatment could be offered. Then, stents capable of retrieving the clot material blocking a blood vessel in an ischemic stroke were developed. Now, if a patient is seen quickly after onset the clot material can be swiftly removed, thereby saving a great deal of brain function, that would otherwise be lost.


Still, many challenges remain, in the removal of a clot that blocks a cerebral artery. One of these challenges is the tendency of fragments of material to break off of the clot as it is being removed, flow in the direction of blood flow, and lodge anew in some narrow cerebral artery, causing a secondary stroke, which can be damaging.


Notably, different types of clots have varying physical properties. Clots that form in the cerebral arteries, through an accumulation of material tend to have the consistency of gelatin. Some clots, however, form from material that has been deposited over time in the atria of the heart, and then breaks off (sometimes as the result of heart surgery) and travels to the cerebral arteries. This material has a consistency more similar to that of peanut butter. Finally, there are clots caused by material deposited in the aorta that breaks off and travels to the cerebral arteries. This material is typically harder than the material from the other two types of clots.


SUMMARY

The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tools and methods which are meant to be exemplary and illustrative, not limiting in scope. In various embodiments, one or more of the above-described problems have been reduced or eliminated, while other embodiments are directed to other improvements.


In a first separate aspect, the present invention may take the form of a stent retriever assembly having a proximal end and a distal end and including a mesh tube having a distal and proximal end and being connected to a first wire. Also, a blood-porous fragment guard is at the distal end of the mesh tube and has a central hub and extends radially and proximally from the central hub. Further, a second wire is connected to the central hub, and when this second wire is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form.


In a second separate aspect, the present invention may take the form of a method of removing a clot from an artery, that utilizes a stent retriever assembly having a proximal end and a distal end. This stent retriever has a mesh tube having a distal and proximal end and being connected to a first wire and a blood-porous fragment guard at the distal end of the mesh tube. This fragment guard includes a central hub and extends radially and proximally from the central hub. Further, a second wire is connected to the central hub, and when this second wire is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form. In the method, the stent retriever is moved to a proximal side of the clot and is pushed through the clot. Then the second wire is pulled relative to the first wire, thereby widening the fragment guard and the stent retriever is pulled proximally to pull material from the clot proximally.


In a third separate aspect, the present invention may take the form of a stent retriever catheter assembly having a proximal end and a distal end, and including a catheter, having a flexible tube sized to fit through the arterial system of a person, and to reach a blood clot in an artery. A first and second wire extend through the tube and a handle is connected to the first and second wires, which can be advanced and retracted with at least 1 cm of independence relative to each other. Further, a mesh tube having a distal and proximal end is connected at its proximal end to the first wire. Finally, a blood-porous fragment guard is at the distal end of the mesh tube, includes a central hub, and extends radially and proximally from the central hub. When the second wire is connected to the central hub, and is pulled proximally relative to the first wire, the hub is pulled proximally, which thereby causes the fragment guard to deploy in expanded form.


In addition to the exemplary aspects and embodiments described above, further aspects and embodiments will become apparent by reference to the drawings and by study of the following detailed descriptions.





BRIEF DESCRIPTION OF THE DRAWINGS

Exemplary embodiments are illustrated in referenced drawings. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than restrictive.



FIG. 1 is an isometric view of a stent retriever according to the present invention.



FIG. 2 is a sectional view of an artery clogged by a clot, with the stent retriever of FIG. 1 piercing the clot.



FIG. 3 is the sectional view of FIG. 2, with the stent retriever of FIG. 1 deployed.



FIG. 4 is the sectional view of FIG. 2, with the stent retriever of FIG. 1 further expanded and in the process of removing the clot.



FIG. 5 is an isometric view of a catheter assembly, including a handle assembly, that could be used to control the stent retriever of FIGS. 1-4.



FIG. 6 is an isometric view of an alternative embodiment of a catheter assembly, according to the present invention.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring to FIGS. 1 and 2, in a preferred embodiment, a stent retriever 10 includes a wire mesh 12 (also referred to as a “mesh tube”) and a woven fragment guard 14. It is controlled by a pair of wires 18A and 18B, which must be separately advanceable for the stent retriever 10 to work correctly. The stent retriever 10 is positioned in an artery 20, near a clot 22 by introduction of a catheter 16. After a distal end of catheter 16 is positioned near clot 22, the stent retriever 10 is deployed by pushing wires 18A and 18B forward. A system for permitting this action is shown and described in U.S. Pat. No. 8,876,863. After or during deployment the stent retriever 10 is pushed through clot 22, so that at least the fragment guard 14 is pushed all the way through.


Referring also to FIG. 3, wire 18B is the advanced relative to wire 18A. Fragment guard 14 is made of a set of spokes 24 that meet in an apex 26 (also referred to as a “central hub”), and are all covered by a fabric 28. When wire 18B is advanced, or wire 18A is retracted, then spokes 24 are spread apart (much as the spokes of an umbrella). The stent retriever is now pulled proximally, bringing the clot 22 with it, and with fragment guard 14 protecting the artery 20 further on in the direction of blood flow, from fragments that could break off from clot 22. Referring to FIG. 4, as the stent retriever 10 is pulled toward the incision where catheter 16 was introduced, artery 20 will typically widen. Wire 18A may be pulled further back relative to wire 18B, thereby widening out fragment guard 14. Wires 18B and 18A each support a radiopaque marker 40 and 42, respectively, to aid a surgeon in locating the stent retriever during a procedure. The two markers 40 and 42 are spaced apart and mutually distinguishable, to aid a surgeon in determining the orientation of stent retriever 10. In an alternative preferred embodiment, marker 42 is closer to the distal tip of retriever 10.


In one preferred embodiment, wire mesh 12 and spokes 24 are made of nitinol. In another preferred embodiment, mesh 12 and spokes 24 are made of a titanium alloy. In one embodiment, fabric 28 is made of woven strands of expanded polytetrafluoroethylene (ePTFE). In one embodiment, the weave is loose, to permit blood to flow through the interstices of the threads. In still another embodiment, the fabric 28 is made of threads arranged in a circular manner about said spokes, to form a pattern similar to that of a spider web.


Referring to FIG. 5, catheter 16 is connected to a handle 44, having separately positionable positioners 46A and 46B, for wires 18A and 18B. Handle 44 permits a user to separately move wire 18A and 18B, for deployment and control of the fragment guard 14.


Referring to FIG. 6, in an alternative embodiment of a stent retriever 110, a wire mesh 112 is partially interwoven with a tape 113. Tape 113 provides a further means of retaining clot material, as the retriever is withdrawn from a patient's vasculature. It is more difficult, however, to push the portion of wire mesh 112 covered with this tape 113 through clot material, so typically the surgeon would have to push retriever 110 through the clot material to the point where tape 113 cleared the clot material before deploying retriever 110. Accordingly, various embodiments of retriever 110, with tape 113 interwoven into the most distal 0.1, 0.2, 0.3, . . . 0.8, 0.9 portion of the wire mesh 112 are disclosed here. Tape 113 is, in a preferred embodiment, polytetrafluoroethylene (PTFE) tape. A fragment guard 114 is, in this instance, not made of a woven material, but either of silicone, polyurethane, or a similar soft polymeric material, either without any apertures, or with a set of apertures having diameters, in various embodiments, in the range of 40 to 100 microns.


INDUSTRIAL APPLICABILITY

The invention has industrial applicability in the field of manufacturing devices to aid surgeons in clearing a blood vessel of a clot.


While a number of exemplary aspects and embodiments have been discussed above, those possessed of skill in the art will recognize certain modifications, permutations, additions and sub-combinations thereof. It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions and sub-combinations as are within their true spirit and scope.

Claims
  • 1. A method of removing a clot from an artery, comprising: (a) providing a stent retriever assembly having a proximal end and a distal end, and including: (i) a mesh tube having a distal and proximal end, and being connected to a first wire; and(ii) a blood-porous fragment guard mounted at said distal end of said mesh tube, said fragment guard including a central hub and extending radially and proximally from said central hub, and wherein a second wire is connected to said central hub, and wherein when said second wire is pulled proximally relative to said first wire, said hub is pulled proximally, which thereby causes said fragment guard to deploy in expanded form;(b) deploying said stent retriever to a proximal side of said clot;(c) pushing said stent retriever through said clot;(d) pulling said second wire relative to said first wire, thereby widening said fragment guard; and(e) pulling said stent retriever proximally to pull material from said clot proximally; wherein said blood clot is in a narrow artery, and wherein as said stent retriever is pulled proximally through the artery, said artery widens and said second wire is pulled further proximally relative to said first wire, causing said fragment guard to widen further to more closely conform to the wider arterial walls.
  • 2. The method of claim 1, wherein said blood clot is in a cranial artery.
  • 3. The method of claim 1, wherein said stent retriever assembly includes a radiopaque element, and wherein during performance of the method location of said stent retriever assembly is monitored by means of said radiopaque element.
  • 4. The method of claim 1, wherein said fragment guard includes spokes, and wherein when said second wire is pulled proximally relative to said first wire, the hub moves proximally and causes said spokes to spread out, which thereby causes said fragment guard to deploy in expanded form.
  • 5. The method of claim 4, wherein said fragment guard, in addition to said spokes, includes threads extending across and between said spokes, to create a finer mesh, better able to hold clot material.
RELATED APPLICATIONS

This application is a continuation-in-part of international application PCT/US17/61685, filed Nov. 15, 2017, which itself is a continuation of U.S. application Ser. No. 15/627,806, filed Jun. 20, 2017, now U.S. Pat. No. 9,848,906, issued Dec. 26, 2017, both of which are incorporated by reference as if fully set forth herein.

US Referenced Citations (128)
Number Name Date Kind
4762129 Bonzel Aug 1988 A
4794931 Yock Jan 1989 A
4932413 Sbockey Jun 1990 A
5160321 Sahota Nov 1992 A
5254088 Lundquist et al. Oct 1993 A
5509900 Kirkman Apr 1996 A
5571173 Perodi Nov 1996 A
5735289 Pfeffer et al. Apr 1998 A
5827324 Cassell Oct 1998 A
6010517 Baccaro Jan 2000 A
6059822 Kenesaka et al. May 2000 A
6142987 Tsugita Nov 2000 A
6283991 Cox et al. Sep 2001 B1
6309399 Barbut Oct 2001 B1
6344041 Kupiecki et al. Feb 2002 B1
6371972 Wallace et al. Apr 2002 B1
6391044 Yadav et al. May 2002 B1
6540722 Boyle Apr 2003 B1
6558405 McInnes May 2003 B1
6652556 Van Tassel et al. Nov 2003 B1
6695813 Boyle Feb 2004 B1
6712766 Harada Mar 2004 B2
6716237 Alt Apr 2004 B1
7160318 Greenberg et al. Jan 2007 B2
7195636 Avellanet et al. Mar 2007 B2
7226475 Lenz et al. Jun 2007 B2
7621928 Thramann et al. Nov 2009 B2
7662168 McGuckin et al. Feb 2010 B2
7927350 Rabbitte Apr 2011 B2
8123796 Kasprzak Feb 2012 B2
8512399 Lafontaine Aug 2013 B2
8529614 Berez et al. Sep 2013 B2
8545530 Eskridge Oct 2013 B2
8551132 Eskridge et al. Oct 2013 B2
8556930 Ellingwood Oct 2013 B2
8668729 Kaufmann et al. Mar 2014 B2
8734504 Kelly May 2014 B2
8753362 Widomski et al. Jun 2014 B2
8814925 Hillaire Aug 2014 B2
8852205 Brady Oct 2014 B2
8876863 Eskridge Nov 2014 B2
8911490 Perkins et al. Dec 2014 B2
9402708 Holloway Aug 2016 B2
9456834 Folk Oct 2016 B2
9463036 Brady Oct 2016 B2
9848906 Eskridge Dec 2017 B1
20020004667 Adams Jan 2002 A1
20020013616 Carter et al. Jan 2002 A1
20020022858 Demond Feb 2002 A1
20020026211 Khosravi Feb 2002 A1
20020042626 Hanson Apr 2002 A1
20020072730 McGill et al. Jun 2002 A1
20020103501 Diaz Aug 2002 A1
20020107534 Schaefer et al. Aug 2002 A1
20020138133 Lenz et al. Sep 2002 A1
20020156457 Fisher Oct 2002 A1
20020165576 Boyle Nov 2002 A1
20020165601 Clerc Nov 2002 A1
20030109917 Rudin Jun 2003 A1
20030163158 White Aug 2003 A1
20040034386 Fulton et al. Feb 2004 A1
20040038460 Scott Feb 2004 A1
20040122466 Bales Jun 2004 A1
20040199197 Eidenschink et al. Oct 2004 A1
20050060017 Fischell et al. Mar 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050283182 Pierce et al. Dec 2005 A1
20060058834 Do et al. Mar 2006 A1
20060106421 Teoh May 2006 A1
20060135943 Mandrusov et al. Jun 2006 A1
20060224179 Kuharczyk et al. Oct 2006 A1
20060264905 Eskridge et al. Nov 2006 A1
20060271154 Woodall Nov 2006 A1
20060287668 Fawzi Dec 2006 A1
20070088387 Eskridge et al. Apr 2007 A1
20070191884 Eskridge et al. Aug 2007 A1
20070299461 Elliott Dec 2007 A1
20080004687 Barbut et al. Jan 2008 A1
20080039929 Davis et al. Feb 2008 A1
20080140051 Bei Jun 2008 A1
20080243170 Jenson et al. Oct 2008 A1
20090024157 Anukhin Jan 2009 A1
20090082803 Adams et al. Mar 2009 A1
20090132024 Berkhoff May 2009 A1
20090171274 Harlev et al. Jul 2009 A1
20090192405 Carney Jul 2009 A1
20090292307 Razack Nov 2009 A1
20090326640 Yoshimura et al. Dec 2009 A1
20100042201 Sherif Feb 2010 A1
20100057019 Zelenka Mar 2010 A1
20100087850 Razack Apr 2010 A1
20100087908 Hilaire Apr 2010 A1
20100234878 Hruska et al. Sep 2010 A1
20100280534 Sher Nov 2010 A1
20110040314 McGuckin, Jr. et al. Feb 2011 A1
20110040319 Fulton, III Feb 2011 A1
20110046669 Goraltchouk et al. Feb 2011 A1
20110112614 Haarer May 2011 A1
20110118769 Bliss et al. May 2011 A1
20110125181 Brady May 2011 A1
20110137334 Anderson et al. Jun 2011 A1
20110160833 Gonzalez et al. Jun 2011 A1
20110190863 Ostroot Aug 2011 A1
20110196414 Porter Aug 2011 A1
20120046676 Morsi Feb 2012 A1
20120053596 Gordon Mar 2012 A1
20120071911 Sadasivan et al. Mar 2012 A1
20120130408 Shur et al. May 2012 A1
20130090682 Bachman et al. Apr 2013 A1
20130197567 Brady Aug 2013 A1
20130204290 Clarke et al. Aug 2013 A1
20130345738 Eskridge Dec 2013 A1
20140005651 Eskridge Jan 2014 A1
20140074149 Garcia et al. Mar 2014 A1
20140094896 Berez et al. Apr 2014 A1
20140114342 Berez et al. Apr 2014 A1
20140121672 Folk May 2014 A1
20140172071 Berez et al. Jun 2014 A1
20140296889 Avneri Oct 2014 A1
20150173782 Garrison Jun 2015 A1
20150313732 Fulton, III Nov 2015 A1
20160022291 Johnson Jan 2016 A1
20160120570 Kobayashi May 2016 A1
20160206426 Khoynezhad Jul 2016 A1
20170112513 Marchand Apr 2017 A1
20170112514 Marchand Apr 2017 A1
20170119408 Ma May 2017 A1
20170128089 Ma May 2017 A1
Foreign Referenced Citations (17)
Number Date Country
1645242 Apr 2006 EP
1955661 Aug 2008 EP
2308383 Jun 2014 EP
2407466 Dec 2010 RU
9000371 Jan 1990 WO
9825656 Jun 1998 WO
9956801 Nov 1999 WO
0128434 Apr 2001 WO
0135839 May 2001 WO
03099168 Dec 2003 WO
2005037129 Apr 2005 WO
2011106426 Sep 2011 WO
2012120490 Sep 2012 WO
2012167156 Dec 2012 WO
2013109784 Jul 2013 WO
2014047650 Mar 2014 WO
2016049529 Mar 2016 WO
Non-Patent Literature Citations (2)
Entry
Machi Paolo et al. Solitaire FR thrombectomy system: immediate results in 56 1-22 consecutive acute ischemic stroke patients. J Neurointervent Surg 2012; 4(1):pp. 62-66, procedure, fig. 1,2.
International Search Report and Written Opinion issued by ISA Australia Patent Office dated Mar. 7, 2018 for related PCT international application PCT/US2017/061685.
Related Publications (1)
Number Date Country
20200121355 A1 Apr 2020 US
Continuations (1)
Number Date Country
Parent 15627806 Jun 2017 US
Child PCT/US2017/061685 US
Continuation in Parts (1)
Number Date Country
Parent PCT/US2017/061685 Nov 2017 US
Child 16724065 US